Journal of Hematopathology

, Volume 3, Issue 1, pp 19–22

NK cell lymphoma, nasal type, with massive lung involvement: a case report

  • Anamarija Morovic
  • Igor Aurer
  • Snjezana Dotlic
  • Dennis D. Weisenburger
  • Marin Nola
Case Report


Extranodal NK/T cell lymphoma, nasal type, is an Epstein–Barr virus-associated lymphoma that most commonly involves the nasal cavity and upper respiratory tract. Lung involvement by NK/T cell lymphoma is rare and seldom reported in the literature. We describe the unusual case of a 41-year-old male with NK cell lymphoma, nasal type, who presented with massive secondary lung involvement 2.5 years after the detection of a retroperitoneal mass. The diagnosis was made by open lung biopsy. Despite aggressive treatment, the patient died shortly after the initiation of therapy. Lung involvement by NK/T cell lymphoma occurs most commonly as part of widely disseminated disease and carries a poor prognosis for the patient. Novel agents and innovative therapies need to be developed for this aggressive lymphoma.


Extranodal NK/T lymphoma Lung involvement Epstein–Barr virus 


  1. 1.
    Chan JKC, Quintanilla-Martinez L, Ferry JA, Peh SC (2008) Extranodal NK/T-cell lymphoma, nasal type. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) World Health Organization classification of tumors: tumors of haematopoietic and lymphoid tissues. IARC, Lyon, pp 285–288Google Scholar
  2. 2.
    Nava VE, Jaffe ES (2005) The pathology of NK-cell lymphomas and leukemias. Adv Anat Pathol 2:27–34CrossRefGoogle Scholar
  3. 3.
    Pagano L, Gallamini A, Trape G et al (2006) NK/T-cell lymphomas nasal type: an Italian multicentric retrospective study. Ann Oncol 17:794–800CrossRefPubMedGoogle Scholar
  4. 4.
    Al-Hakeem DA, Fedele S, Carlos R, Porter S (2007) Extranodal NK/T-cell lymphoma, nasal type. Oral Oncol 43:4–14CrossRefPubMedGoogle Scholar
  5. 5.
    Suzuki R, Takeuchi K, Ohshima K, Nakamura S (2008) Extranodal NK/T-cell lymphoma: diagnosis and treatment cues. Hematol Oncol 26:66–72CrossRefPubMedGoogle Scholar
  6. 6.
    Aviles A, Neri N, Fernandez R et al (2003) Nasal NK/T-cell lymphoma with disseminated diseases treated with aggressive combined therapy. Med Oncol 20:2013–2017Google Scholar
  7. 7.
    Laohaburanakit P, Hardin KA (2006) NK/T cell lymphoma of the lung: a case report and review of literature. Thorax 61:267–270CrossRefPubMedGoogle Scholar
  8. 8.
    Lee BH, Kim SY, Kim MY et al (2006) CT of nasal-type T/NK cell lymphoma in the lung. J Thorac Imaging 21:37–39CrossRefPubMedGoogle Scholar
  9. 9.
    Kuwabara H, Tsuji M, Yoshii Y et al (2003) Nasal-type NK/T cell lymphoma of the orbit with distant metastases. Hum Pathol 34:290–292CrossRefPubMedGoogle Scholar
  10. 10.
    Se C, Lee SY, Choi JH et al (2002) Cutaneous dissemination of nasal NK/T-cell lymphoma with bone marrow, liver and lung involvement. Clin Exp Dermatol 27:120–122CrossRefGoogle Scholar
  11. 11.
    Lee J, Suh C, Park YH et al (2006) Extranodal natural killer T-cell lymphoma, nasal type: a prognostic model from a retrospective multicenter study. J Clin Oncol 24:612–618CrossRefPubMedGoogle Scholar
  12. 12.
    Lee J, Park YH, Kim WS et al (2005) Extranodal nasal type, NK/T-cell lymphoma: elucidating clinical prognostic factors for risk based stratification of therapy. Eur J Cancer 41:1402–1408CrossRefPubMedGoogle Scholar
  13. 13.
    Au W, Weisenburger DD, Intragumtornchai T et al (2009) Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 113:3931–3937CrossRefPubMedGoogle Scholar
  14. 14.
    Kim TM, Lee SY, Jeon YK et al (2008) Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group. Ann Oncol 19:1477–1484CrossRefPubMedGoogle Scholar
  15. 15.
    Cheung MMC, Chan JK, Lau W, Ngan RKC, Foo WWL (2002) Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 54:182–190PubMedGoogle Scholar
  16. 16.
    Kim TM, Park YH, Lee SY et al (2005) Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage IE/IIE extranodal NK/T-cell lymphoma, nasal type. Blood 106:3785–3790CrossRefPubMedGoogle Scholar
  17. 17.
    Kim WY, Jeon YK, Kim TM et al (2009) Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma. Ann Oncol 20:1688–1696CrossRefPubMedGoogle Scholar
  18. 18.
    Barrionuevo C, Zaharia M, Martinez MT et al (2007) Extranodal NK/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru. Appl Immunohistochem Mol Morphol 15:38–44CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Anamarija Morovic
    • 1
  • Igor Aurer
    • 2
  • Snjezana Dotlic
    • 4
  • Dennis D. Weisenburger
    • 3
  • Marin Nola
    • 4
  1. 1.Department of Pathology and Laboratory MedicineUniversity of Cincinnati College of MedicineCincinnatiUSA
  2. 2.Department of Internal MedicineZagreb University Hospital CenterZagrebCroatia
  3. 3.Department of Pathology and MicrobiologyUniversity of Nebraska Medical CenterOmahaUSA
  4. 4.Department of PathologyZagreb University Hospital CenterZagrebCroatia

Personalised recommendations